Relive Health, one of the nation’s fastest-growing providers of integrative and regenerative care, has partnered with Dr.

A research team at Lund University in Sweden has discovered a mechanism that helps acute myeloid leukemia cells to evade the ...

CD19-targeting UB-VV11 became the first in vivo CAR-T cell therapy to be cleared for human testing by the FDA last year, and ...

Last month, in a tiny room in Manchester, UK, a niche group of biology scientists gathered to discuss if they needed to restrict research in an emerging technology that might affect humans and ...

In leukemia, IGF2BP3 protein guides cancer cells to proliferate by enhancing their RNA regulation. These cells rely on ...

Erwin Zimmermann's right arm trembles and his upper body bends forward slightly. He takes smaller steps and he doesn't sleep ...

Japanese scientists successfully eliminated cancer tumors using live bacteria, a new therapy that acts independently of the ...

From bispecific engineering to clinically relevant data sourcing, evolving antibody technologies advance oncology therapeutics.

According to MarketsandMarkets™, The omega-3 market is estimated to be USD 4,362.2 million in 2025 and is projected to reach USD 7,756.4 million by 2030, at a CAGR of 12.2% from 2025 to 2030.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has granted approval for Zepzelca® (lurbinectedin) in combination with atezolizumab (Tecentriq® ...